A single nucleotide polymorphism in the phospholipase D1 gene is associated with risk of non-small cell lung cancer

International Journal of Biomedical Science

Volumn 8, Issue 2, 2012, Pages 121-128

  Ahn, Myung Ju ^b   Park, Shin Young ^a   Kim, Won Kyu ^a   Cho, Ju Hwan ^a   Chang, Brian Junho ^c   Kim, Dong Jo ^d   Ahn, Jin Seok ^b   Park, Keunchil ^b   Han, Joong Soo ^a  

^a Hanyang University   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarker; DGGE; Lung cancer; NSCLC; Phospholipase D; Single nucleotide polymorphism

Indexed keywords

PHOSPHOLIPASE D1;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; EXON; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; MUTATOR GENE; PHOSPHOLIPASE D1 GENE; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84865373630     PISSN: 15509702     EISSN: 15552810     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Cho JH, Hong SK, Kim EY, Park SY, et al. Overexpression of phospholipase D suppresses taxotere-induced cell death in stomach cancer cells. Biochim. Biophys. Acta. 2008; 1783 (5): 912-923.
2. Park SY, Cho JH, Oh DY, Park JW, et al. House dust mite allergen Der f 2-induced phospholipase D1 activation is critical for the production of interleukin-13 through activating transcription factor-2 activation in human bronchial epithelial cells. J. Biol. Chem. 2009; 284 (30): 20099-20110.
3. Uchida N, Okamura S, Nagamachi Y, Yamashita S. Increased phospholipase D activity in human breast cancer. J. Cancer Res. Clin. Oncol. 1997; 123 (5): 280-285.
4. Uchida N, Okamura S, Kuwano H. Phospholipase D activity in human gastric carcinoma. Anticancer Res. 1999; 19 (1B): 671-675.
5. Hsu YL, Hung JY, Ko YC, Hung CH, et al. Phospholipase D signaling pathway is involved in lung cancer-derived IL-8 increased osteoclastogenesis. Carcinogenesis. 2010; 31 (4): 587-596.
6. Noh DY, Ahn SJ, Lee RA, Park IA, et al. Overexpression of phospholipase D1 in human breast cancer tissues. Cancer Lett. 2000; 161 (2): 207-214.
7. Zhao Y, Ehara H, Akao Y, Shamoto M, et al. Increased activity and intranuclear expression of phospholipase D2 in human renal cancer. Biochem. Biophys. Res. Commun. 2000; 278 (1): 140-143.
8. Lei Z, Liu RY, Zhao J, Liu Z, et al. TGFBR1 haplotypes and risk of non-small-cell lung cancer. Cancer Res. 2009; 69 (17): 7046-7052.
9. Spinola M, Leoni VP, Galvan A, Korsching E, et al. Genome-wide single nucleotide polymorphism analysis of lung cancer risk detects the KLF6 gene. Cancer Lett. 2007; 251 (2): 311-316.
10. Engels EA, Wu X, Gu J, Dong Q, et al. Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer. Cancer Res. 2007; 67 (13): 6520-6527.
11. Park JY, Park JM, Jang JS, Choi JE, et al. Caspase 9 promoter polymorphisms and risk of primary lung cancer. Hum. Mol. Genet. 2006; 15 (12): 1963-1971.
12. Shields PG. Molecular epidemiology of smoking and lung cancer. Oncogene. 2002; 21 (45): 6870-6876.
13. Larsen JE, Colosimo ML, Yang IA, Bowman R, et al. CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung. Carcinogenesis. 2006; 27 (3): 525-532.
14. Wenzlaff AS, Cote ML, Bock CH, Land SJ, et al. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study. Carcinogenesis. 2005; 26 (12): 2207-2212.
15. Le Marchand L, Donlon T, Lum-Jones A, Seifried A, et al. Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk. Cancer Epidemiol. Biomarkers Prev. 2002; 11 (4): 409-412.
16. Ito H, Matsuo K, Hamajima N, Mitsudomi T, et al. Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk. Carcinogenesis. 2004; 25 (8): 1395-1401.
17. Tsuge M, Hamamoto R, Silva FP, Ohnishi Y, et al. A variable number of tandem repeats polymorphism in an E2F-1 binding element in the 5' flanking region of SMYD3 is a risk factor for human cancers. Nat. Genet. 2005; 37 (10): 1104-1107.
18. Cebrian A, Pharoah PD, Ahmed S, Ropero S, et al. Genetic variants in epigenetic genes and breast cancer risk. Carcinogenesis. 2006; 27 (8): 1661-1669.
19. Yoon KA, Hwangbo B, Kim IJ, Park S, et al. Novel polymorphisms in the SUV39H2 histone methyltransferase and the risk of lung cancer. Carcinogenesis. 2006; 27 (11): 2217-2222.
20. Cargill M, Altshuler D, Ireland J, Sklar P, et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat. Genet. 1999; 22 (3): 231-238.
21. Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic. Acids. Res. 2002; 30 (17): 3894-3900.
22. Wang DG, Fan JB, Siao CJ, Berno A, et al. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science. 1998; 280 (5366): 1077-1082.
23. Chen Y, Rodrik V, Foster DA. Alternative phospholipase D/mTOR survival signal in human breast cancer cells. Oncogene. 2005; 24 (4): 672-679.
24. Kim KO, Lee KH, Kim YH, Park SK, et al. Anti-apoptotic role of phospholipase D isozymes in the glutamate-induced cell death. Exp. Mol. Med. 2003; 35 (1): 38-45.
25. Park MA, Lee MJ, Lee SH, Jung DK, et al. Anti-apoptotic role of phospholipase D in spontaneous and delayed apoptosis of human neutrophils. FEBS Lett. 2002; 519 (1-3): 45-49.
26. Meacci E, Vasta V, Moorman JP, Bobak DA, et al. Effect of Rho and ADP-ribosylation factor GTPases on phospholipase D activity in intact human adenocarcinoma A549 cells. J. Biol. Chem. 1999; 274 (26): 18605-18612.
27. Meacci E, Nuti F, Catarzi S, Vasta V, et al. Activation of phospholipase D by bradykinin and sphingosine 1-phosphate in A549 human lung adenocarcinoma cells via different GTP-binding proteins and protein kinase C delta signaling pathways. Biochemistry. 2003; 42 (2): 284-292.
28. Yamada Y, Hamajima N, Kato T, Iwata H, et al. Association of a polymorphism of the phospholipase D2 gene with the prevalence of colorectal cancer. J. Mol. Med. 2003; 81 (2): 126-131.
29. Yamada Y, Banno Y, Yoshida H, Kikuchi R, et al. Catalytic inactivation of human phospholipase D2 by a naturally occurring Gly901Asp mutation. Arch. Med. Res. 2006; 37 (6): 696-699.
30. Elf J, Nilsson D, Tenson T, Ehrenberg M. Selective charging of tRNA isoacceptors explains patterns of codon usage. Science. 2003; 300 (5626): 1718-1722.